Uus ajastu HCV ravis – mis on muutunud
8?journalCode=ierz20 (02.05.2018)
4. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a
systematic review and meta-analysis Marcus M Mücke, MD, Lisa I Backus, MD, Victoria
T Mücke, MD et.al https://www.thelancet.com/journals/langas/article/PIIS2468-
1253(18)30002-5/fulltext (03.05.2018)
5. Hepatitis C Treatment and Barriers to Eradication, Monica A. Konerman, Anna S. F. Lok
http://www.nature.com.ezproxy.utlib.ut.ee/articles/ctg201650.pdf (07.05.2018)
6. Direct-Acting Antiviral Agents for Hepatitis C Virus Infection Jennifer J. Kiser and
Charles Flexner https://www-annualreviews-
org.ezproxy.utlib.ut.ee/doi/pdf/10.1146/annurev-pharmtox-011112-140254 (07.05.2018)
7. http://www.who.int/en/news-room/fact-sheets/detail/hepatitis-c (07.05. 2018)
8. Review of boceprevir and telaprevir for the treatment of chronic hepatitis C Kyle J Wilby,
BSP ACPR, Nilufar Partovi, PharmD, Jo-Ann E Ford et.al
annaabi.ee 
